Key result
Asplenia is linked to markedly lower 1-year survival than polysplenia in heterotaxy syndrome, ~53% vs 94%.
Why the study?
Surgical outcomes in patients with heterotaxy syndrome remain poor, especially in those with complex anatomical variants such as nonconfluent pulmonary arteries.
What are the surgical outcomes and survival rates in patients with heterotaxy syndrome undergoing surgical repair?
Cohort (n=27)
No
What are the surgical outcomes and survival rates in patients with heterotaxy syndrome undergoing surgical repair?
Surgical outcomes for heterotaxy syndrome are satisfactory for polysplenia but remain poor for asplenia, with nonconfluent pulmonary arteries significantly increasing mortality risk.
May guide heterotaxy prognosis by splenic phenotype; hypothesis-generating for subtype-specific interventions.
Heterotaxy syndrome encompasses a wide range of anatomical variants including poor pulmonary vascular development. Surgical outcome remains poor in this difficult subgroup. Between April 1996 and November 2004, 27 patients with visceral heterotaxy were enrolled in this study. The median age at presentation was 25 days. There were 11 patients with asplenia and 16 with polysplenia. There were 5 deaths (4 in patients with asplenia, 1 in a patient with polysplenia). All patients with asplenia were scheduled for single-ventricle repair, and 5 completed a modified Fontan procedure. Of the 16 patients with polysplenia, 8 completed 2-ventricle repair and 6 had a modified Fontan. In polysplenia, actuarial survival was 93.8% at 4 months, and remained constant thereafter. In asplenia, survival was 81.8% at 1 month, and 53.0% at 1 year. A significant correlation was found between nonconfluent pulmonary arteries and mortality. The medium-term result in polysplenia was satisfactory, but not in asplenia. Nonconfluent pulmonary arteries carry a high risk of mortality, and a strategy to create pulmonary vascular confluence and satisfactory pulmonary blood flow is mandatory.
No takes yet. Share an insight, caveat, or question.
Takeuchi et al. (2006) conducted a cohort in Heterotaxy syndrome (n=27). Asplenia vs. Polysplenia was evaluated on Actuarial survival at 1 year. In patients with heterotaxy syndrome, actuarial survival at 1 year was 53.0% for those with asplenia compared to 93.8% for those with polysplenia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Asian Cardiovascular and Thoracic Annals